BFA
NAGE

BlackRock Fund Advisors’s Niagen Bioscience NAGE Stock Holding History

BlackRock Fund Advisors’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.96M Buy
895,458
+118,684
+15% +$322K ﹤0.01% 3083
2016
Q3 		$2.31M Buy
776,774
+31,978
+4% +$117K ﹤0.01% 3126
2016
Q2 		$3.08M Buy
+744,796
New +$3.52M ﹤0.01% 3060

Other funds holding NAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.65B AUM 20.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BlackRock Fund Advisors's NAGE Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Niagen Bioscience (NAGE) stake by 15% in Q4 2016, buying an estimated $322K and bringing the position to 895,458 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3083.

BlackRock Fund Advisors first reported a position in NAGE in Q2 2016 and has held it in 3 quarters since. The position peaked at $3.08M in Q2 2016. 52 funds tracked by Wall St. Rank hold NAGE as of Q4 2016.

  • BlackRock Fund Advisors held 895,458 shares of Niagen Bioscience worth $2.96M as of Q4 2016.
  • BlackRock Fund Advisors bought 118,684 Niagen Bioscience shares in Q4 2016, an estimated $322K.
  • Niagen Bioscience made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3083 holding.
  • BlackRock Fund Advisors first reported a position in Niagen Bioscience in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Fund Advisors's Niagen Bioscience position peaked at $3.08M in Q2 2016.
  • 52 funds tracked by Wall St. Rank held Niagen Bioscience as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.